Extranodal lymphoma of MALT-type: Perspective at the beginning of the 21st century

Expert Review of Anticancer Therapy

Volumn 1, Issue 1, 2001, Pages 53-64

  Raderer, Markus ^a   Isaacson, Peter G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chemotherapy; Helicobacter pylori; Lymphoma; Mucosa associated lymphoid tissue (MALT); Radiation; Surgery

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; NUCLEOSIDE ANALOG; PREDNISONE; VINCRISTINE;

BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL TRIAL; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOSCOPIC BIOPSY; ERADICATION THERAPY; GASTROSCOPY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTESTINE RADIOGRAPHY; MEDICAL DECISION MAKING; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH LYMPHOMA; STOMACH SURGERY; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 0035560236     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.1.1.53     Document Type: Review

References (108)

1. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas
2. Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites
3. Primary gastric lymphoma
4. Primary malignant lymphoid tumors of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis
5. Gastrointestinal involvement in non-Hodgkin's lymphoma
6. Malignant lymphoma of mucosa associated lymphoid tissue. A distinctive type of B-cell lymphoma
7. Extranodal malignant lymphoma arising from mucosa associated lymphoid tissue
8. Human Peyer's patches: An immunohistochemical study
9. The human gut contains a novel population of B-lymphocytes which resemble marginal zone cells
10. A Revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
11. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track
12. Gastric MALT-lymphoma: From concept to cure
13. Mucosa-associated lymphoid tissue (MALT) and the MALT-lymphoma concept
14. Malignant lymphoma of the thyroid gland
15. Maltoma of the thyroid in a man with Hashimoto's thyroiditis
16. Malignant lymphoma of the salivary glands
17. Primary B cell lymphoma of salivary gland and its relationship to myoepithelial sialadenitis
18. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa associated lymphoid tissue
19. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in the intestinal tract and associated lymphoid tissues
20. Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone
21. Intestinal dissemination of gastric mucosa associated lymphoid tissue lymphoma
22. 7 integrin mediates lymphocytes binding to the mucosal vascular addressin MAdCAM-1
23. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue
24. CD5+ extranodal marginal zone B-cell (MALT) lymphoma
25. CD5 antigen expression in low grade B cell lymphomas of mucosa-associated lymphoid tissue (LGBL/MALT)
26. CD5 expression in a lymphoma of the mucosa associated lymphoid tissue (MALT) - Type as a marker for early dissemination and aggressive clinical behaviour
27. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation
28. Primary hepatic marginal zone B-cell lymphoma with mantle cell lymphoma phenotype
29. Relationship between high-grade lymphoma and low-grade B cell mucosa associated lymphoid tissue lymphoma (MALToma) of the stomach
30. Histological grading and gastric lymphoma: Pre-treatment criteria and clinical relevance
31. A reassessment of primary thyroid lymphoma: High-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma
32. Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue
33. Primary B-cell gastric lymphoma: A clinicopathological study of 145 patients
34. Gastrointestinal malignant lymphomas of the mucosa associated lymphoid tissue: Factors relevant to prognosis
35. Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach
36. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract
37. Genetic aberrations common in gastric high-grade large B-cell lymphoma
38. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa associated lymphoid tissue (MALT)-type
39. Importance of extensive staging in patients with mucosa associated lymphoid tissue (MALT)-type lymphoma
40. Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma
41. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
42. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients
43. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis
44. High incidence of primary gastric lymphoma in Northeastern Italy
45. Helicobacter pylori infection and gastric lymphoma
46. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
47. Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro
48. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation
49. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue
50. Mucosal IgA recognition of Helicobacter pylori 120 kD protein, peptic ulceration and gastric pathology
51. Infection with Helicobacter pylori strains possessing CagA is associated with an increase of developing adenocarcinoma of the stomach
52. Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA
53. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing CagA protein
54. Mucosal humoral response to CagA shows a high prevalence in patients with gastric MALT-type lymphoma
55. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
56. Healing gastric MALT-lymphomas by eradicating H. pylori?
57. Unexpected success of Helicobacter pylori (Hp) eradication in low grade MALT-lymphoma
58. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
59. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
60. Diagnosis and posttreatment follow-up of Helicobacter pylori in gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction or both?
61. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori
62. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma. Follow-up together with sequential molecular studies
63. Biology and treatment of MALT lymphoma: The state of the art in 1996
64. Cure of Helicobacter pylori expression and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma
65. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: An uncontrolled trial
66. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: Results of an ongoing multicenter trial
67. A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma
68. Helicobacter pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: A long-term follow-up study
69. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type
70. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: Follow-up study of 48 cases
71. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT-lymphoma
72. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach
73. Regression of gastric MALT-lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging
74. Primary gastric B-cell lymphoma: Results of a prospective multicenter study
75. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT-type responding to eradication of Helicobacter pylori infection
76. Genetic abnormalities in marginal zone B-cell lymphoma
77. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using AP12 and MLT specific probes
78. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
79. Identification of paracaspases and metacaspases. Two ancient families of caspase-like proteins, one of which plays a key role in MALT-lymphoma
80. Complete remission of gastric high-grade B-cell MALT lymphoma after cure of Helicobacter pylori infection-a case report of 7 patients
81. Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori
82. Helicobacter heilmanii-associated primary gastric low-grade MALT-lymphoma: Complete remission after curing the infection
83. Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune disease and with dyspepsia. A follow-up study
84. Gastric mucosa associated lymphoid tissue in autoimmune thyroid diseases
85. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin
86. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: Analysis of 108 patients
87. Low-grade MALT-lymphoma involving multiple mucosal sites and bone marrow
88. Determination of a common clonal origin of gastric and pulmonary mucosa-associated lymphoid tissue lymphomas presenting five years apart
89. Sequential MALT lymphomas of the stomach, small intestine and gall bladder
90. Low-grade gastric B-cell lymphoma of mucosa associated lymphoid tissue (MALT): A multifocal disease
91. Clonal origin of micro-lymphomas in low-grade B-cell gastric MALT-lymphoma
92. Clone specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastrointestinal mucosa
93. Mucosa associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed
94. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey
95. Klinische Stadieneinteilung der non-Hodgkin Lymphome
96. Reports on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
97. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients
98. The marginal zone gastric B-cell lymphoma of MALT-type
99. Low-grade MALT-lymphoma of the stomach: A review of treatment options
100. Treatment results of primary stage I and II non-Hodgkin's lymphomas of the stomach
101. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach
102. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone
103. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression
104. Cladribine (2-CDA) as a therapy for low-grade MALT-lymphoma: An organ preserving therapeutic concept
105. Chemotherapy for treatment of primary gastric high-grade B-cell lymphoma in stages IE and IIE
106. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: Analysis of 75 patients
107. Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa
108. Rituximab in the treatment of gastrointestinal (GI) mucosa-associated lymphoid tissue (MALT) lymphoma